CN Patent

CN102985125A — 干粉药物输送系统和方法

Assigned to Mannkind Corp · Expires 2013-03-20 · 13y expired

What this patent protects

本发明涉及干粉药物输送系统和方法，公开了一种肺部药物输送系统，其包括呼吸供能的吸入器和用于输送干粉制剂的药盒。吸入器和药盒可被提供药物输送制剂，其例如包括二酮哌嗪和活性成分，活性成分包括用于治疗疾病和失调(例如诸如糖尿病和/或肥胖症等内分泌疾病)的小有机分子、包括胰岛素和胰高血糖素样肽1等的肽和蛋白质。

USPTO Abstract

本发明涉及干粉药物输送系统和方法，公开了一种肺部药物输送系统，其包括呼吸供能的吸入器和用于输送干粉制剂的药盒。吸入器和药盒可被提供药物输送制剂，其例如包括二酮哌嗪和活性成分，活性成分包括用于治疗疾病和失调(例如诸如糖尿病和/或肥胖症等内分泌疾病)的小有机分子、包括胰岛素和胰高血糖素样肽1等的肽和蛋白质。

Drugs covered by this patent

Patent Metadata

Patent number
CN102985125A
Jurisdiction
CN
Classification
—
Expires
2013-03-20
Drug substance claim
No
Drug product claim
No
Assignee
Mannkind Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.